Tissue-specific and ontogenetic regulation of LIF protein levels determined by quantitative enzyme immunoassay.
To define the physiological role of leukemia inhibitory factor (LIF), it is essential to localize sites of LIF synthesis in vivo. We generated polyclonal antibodies specific for native rat LIF, and developed a two-site immunoassay to detect 10 pg LIF/ml. Using this immunoassay, we determined LIF content of 18 organs, CNS regions, and ganglia throughout postnatal development of rats. High levels of LIF protein (1.0-11.0 ng/g tissue) are present in relatively few tissues: the uterus at late proestrus to estrus and on day 5 of pregnancy, ovary at estrus to early metestrus-1, footpads during early postnatal development and thymus throughout. Intermediate levels (0.5-1.0 ng) are detected in the gut, skin, skeletal muscle, pancreas and lung at one or more postnatal ages. Low levels (0.1-0.5 ng) are observed in most other non-nervous and nervous tissues. LIF protein levels do not completely correspond to reported LIF mRNA levels.
Fukada
K
K
Department of Anatomy and Cell Biology, State University of New York, Health Science Center at Brooklyn 11203, USA. kfukada@netmail.hscbklyn.edu
Korsching
S
S
Towle
M F
MF
D000367:Age Factors; D000818:Animals; D000918:Antibody Specificity; D002490:Central Nervous System / Q000737:chemistry*; D004797:Enzyme-Linked Immunosorbent Assay / Q000379:methods*; D005260:Female; D005724:Ganglia / Q000737:chemistry; D006131:Growth Inhibitors / Q000032:analysis*; D015850:Interleukin-6; D053605:Leukemia Inhibitory Factor; D008222:Lymphokines / Q000032:analysis*; D008297:Male; D009928:Organ Specificity; D011247:Pregnancy; D051381:Rats; D017207:Rats, Sprague-Dawley; D012680:Sensitivity and Specificity; D013950:Thymus Gland / Q000737:chemistry; D014599:Uterus / Q000737:chemistry*
D006131:Growth Inhibitors; D015850:Interleukin-6; D053605:Leukemia Inhibitory Factor; D008222:Lymphokines